BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19339809)

  • 1. Regulation of fibroblast growth factor 23 production in bone in uremic rats.
    Saji F; Shiizaki K; Shimada S; Okada T; Kunimoto K; Sakaguchi T; Hatamura I; Shigematsu T
    Nephron Physiol; 2009; 111(4):p59-66. PubMed ID: 19339809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.
    Saji F; Shigematsu T; Sakaguchi T; Ohya M; Orita H; Maeda Y; Ooura M; Mima T; Negi S
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1212-7. PubMed ID: 20739393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
    Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M
    Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia.
    Mace ML; Gravesen E; Nordholm A; Hofman-Bang J; Secher T; Olgaard K; Lewin E
    Kidney Int; 2017 Jul; 92(1):165-178. PubMed ID: 28341272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
    Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
    Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant FGF23 prevents the progression of chronic kidney disease but aggravates renal osteodystrophy in uremic rats.
    Kusano K; Saito H; Segawa H; Fukushima N; Miyamoto K
    J Nutr Sci Vitaminol (Tokyo); 2009 Apr; 55(2):99-105. PubMed ID: 19436134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model.
    Sugiura H; Matsushita A; Futaya M; Teraoka A; Akiyama KI; Usui N; Nagano N; Nitta K; Tsuchiya K
    PLoS One; 2018; 13(3):e0191706. PubMed ID: 29518087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
    Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo.
    López I; Rodríguez-Ortiz ME; Almadén Y; Guerrero F; de Oca AM; Pineda C; Shalhoub V; Rodríguez M; Aguilera-Tejero E
    Kidney Int; 2011 Sep; 80(5):475-82. PubMed ID: 21525854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E; Canaff L; Fox J; Hendy GN
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
    Kolek OI; Hines ER; Jones MD; LeSueur LK; Lipko MA; Kiela PR; Collins JF; Haussler MR; Ghishan FK
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc nutritional status modifies renal osteodystrophy in uremic rats.
    Kimmel PL; Langman CB; Bognar B; Faugere MC; Chawla LS; Watkins DW; Malluche HH
    Clin Nephrol; 2001 Dec; 56(6):445-58. PubMed ID: 11770796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats.
    Bisson SK; Ung RV; Picard S; Valade D; Agharazii M; Larivière R; Mac-Way F
    J Bone Miner Metab; 2019 Mar; 37(2):212-223. PubMed ID: 29603070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.
    Barthel TK; Mathern DR; Whitfield GK; Haussler CA; Hopper HA; Hsieh JC; Slater SA; Hsieh G; Kaczmarska M; Jurutka PW; Kolek OI; Ghishan FK; Haussler MR
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):381-8. PubMed ID: 17293108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats.
    Jung S; Querfeld U; Müller D; Rudolph B; Peters H; Krämer S
    J Hypertens; 2012 Nov; 30(11):2182-91. PubMed ID: 22902873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.